The purpose of this webinar is to define Pre-exposure Prophylaxis (PrEP), discuss the importance of implementing PrEP in an urban primary care setting, describe the process of prescribing PrEP, and discuss strategies for leveraging resources in an urban area.
The purpose of this webinar is to describe the process of coding for PrEP in WV and PA, discuss the implementation of billing for PrEP, and compare the different options for paying for PrEP.
This webinar will focus on the question of why there is a raging epidemic of addiction. The current opioid epidemic is a symptom of the fraying of the socio-economic fabric of rural United States. We will also look at the reasons why funding should be targeted to substance misuse, not to the drug of the moment.
At the end of the webinar, participants will be able to describe current guidelines and epidemiology for HIV testing among adolescents, identify key steps in educating health professionals on routine HIV testing for adolescents, and discuss lessons learned and how to implement these lessons learned across EHE regions.
This session will describe PrEP and the importance of adherence during the COVID-19 pandemic, barriers to PrEP that have been brought on by COVID-19, strategies to overcome barriers and promote adherence, and how telehealth can be used to promote PrEP.
This webinar will describe the process of vaccine development during COVID-19 and discuss the challenges and opportunities associated with vaccine development.
Abstract: Hepatitis C infection is a growing public health concern, exacerbated by the opioid epidemic that continues to make headlines in Southwestern Pennsylvania and across the United States. With the primary means of transmission being blood borne from percutaneous exposure, the hepatitis C virus (HCV) is most commonly spread among injection drug users through unsafe injection practices. Although measures are being taken to aid individuals with substance use disorder (SUD) access efficacious treatments for cessation, such as Medication Assisted Treatment (MAT), few SUD treatment programs incorporate a hepatitis C education curriculum emphasizing how to prevent infection and transmission of HCV. A group of individuals that often end up being overlooked when considering the long-term burden of HCV infection are pregnant women and their unborn babies, potentially because of the stigma around drug use and pregnancy. There is a need to intervene to improve birth outcomes and improve postpartum HCV treatment adherence in women with SUD.
The proposed public health intervention will incorporate an educational booklet that is based on the Information-Motivation-Behavioral skills (IMB) model. This self-guided booklet will be given to women at risk for pregnancy who are currently involved in SUD treatment in the Greater Pittsburgh Area, and will contain HCV prevention and treatment information, as well as a daily paper diary to be incorporated into their treatment to potentially yield better outcomes because of the behavioral motivation. The ‘Baby and Me, Without Hep C’ booklet program will be a low-cost way for already established pregnancy/SUD centers to potentially lessen the burden of HVC infection on mothers and babies.
Advisor: Dr. Derrick Matthews
Last Updated On Tuesday, April 17, 2018 by Abby Kincaid
Created On Tuesday, April 17, 2018
Click to enter calendar events or share news and announcements.